Inventor · disambiguated record
Violeta L. Marin
Also filed as: MARIN VIOLETA L
1 granted patent·9 pending applications·2 citations·filing 2009–2024
21Inventor score
Top patents by PatentIndex Score
10 records- 0188US12172992B2Pyrimidines for degrading Bruton's tyrosine kinaseABBVIE INC·Filed 2023·Granted Dec 24, 2024·2 cites·3 claims
- 0284US2025177374A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2024·Application pending·0 cites
- 0377US2024058450A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2022·Application pending·0 cites
- 0473US2020246460A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 0569US2025304568A1Pyrimidines for degrading bruton's tyrosine kinaseABBVIE INC·Filed 2024·Application pending·0 cites
- 0662US2019142941A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 0762US2020246323A1Antibody Drug Conjugates with Cell Permeable BCL-XL InhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 0853US2016339117A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2015·Application pending·0 cites
- 0942US2017182179A1Antibody Drug Conjugates with Cell Permeable BCL-XL InhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 1038US2010112722A1Immunoassays and Characterization of Biomolecular Interactions Using Self-Assembled MonolayersMRKSICH MILAN·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Violeta L. Marin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →